代表性课题:
(1)广东省教育厅,广东省普通高校创新国队,2022ZDZX3004,胰岛素抵抗相关代谢性慢病中西医结合防治创新团队,2022-09 至2025-09.100万元,在研,主持
(2)中国生物技术发展中心,国家重点研发计划,2020YFC2006400.健康管理综合服务应用示范,2020-12至2023-12,40万元,在研,主持
(3)佛山市科学技术局,佛山市中医药领域科技攻关先行先试项目,2020001005585,瘀互结相关慢病社区防控关键共性技术与应用研究,2020-06 至 2022-07,670万元,结题,主持
(4)佛山市科学技术局,佛山市新冠肺炎科技攻关专项,2020001000376,基于"全科医学+"医共体的新型冠状病毒肺炎社区立体式防控的规范管理研究,2020-02 至 2022-07,200万元,结题,主持
(5)广东省科学技术厅,广东省自然科学基金项目,2018A0303130346,Axin调控脂质代谢平衡的分子机制研究,2018-05 至 2022-04,10万元,结题,主持
(6)广东首教育厅,广东首学位与研究生教育改革研究项目,2019JGXM21,基于新型医共体的全科专硕“3C"培养模式的构建与前瞻性队列研究,2019-10 至 2021-10,5万元,结题,主持
(7)广东省教育厅,广东省本科高校临床教学基地教学改革项目,2017JG19,基于云技术的在校医学生CPC“全科医学”教学平台,2017-10 至 2019-10,1万元,结题,主持
(8)广州市卫生健康委员会,广州市卫生健康科技重大项目,基于医防融合和慢病多病一体化融合管理理念的广州市慢性病管理创新模式研究,2024年1月~2025年12月,90万,主持
(9)中华人民共和国科学技术部,癌症、心脑血管、呼吸和代谢性疾病防治研究国家科技重大专项,中西医结合降低糖尿病肾脏疾病复合终点事件发生风险的循证评价研究,2024年12月~2028年12月,1730万,分课题负责人
代表性论文:
(1)Xu Zhao; jiancong Lu; Cui Zhang; Chuanxiang Chen; Manting Zhang; Jingyi Zhang; Qingfeng Du; Huijun Wang ; Methamphetamine induces cardiomyopathy through GATA4/NF-KB/SASP axis-mediated cellularsenescence, Toxicology and Applied Pharmacology, 2023,466:116457(期刊论文)
(2)Shaocan Fan: Zhenmiao Deng; QingfengDu; Pingping Pan; Sha Yuan; Xiaohong Huang :Radiofreguency Doppler echocardiography, Measurement, 2023,220:113305 (期刊论文)
(3) Yang Liu; Chengdong Xu; Feiyan Liu; Fengbei Shen: Boya Zhang; jingyi Zhang: Gexin Xiao; NingWang; Ni Lin; $haogi Zhou; Huiun Wang:, QingfengDu:, Spatiotemporal variation in the blood lead levels oChinese children with the environmental Kuznets curve trend, Heliyon, 2022,8(11): e11609 (期刊论文)
(4)Weiwei Gong; Xing Li; Maigeng Zhou; Chunliang Zhou; Yize Xiao; Biao Huang; Lifeng Lin; jianxiongHu, vianpeng Xiao, Welin Zeng; Guanhao He, Cunrui Huang, Tao Liu, QingfengDu, Wenjun Ma : Mortality burden attributable to temperature variability in China, yournal of Exposure $cience & Environmental Epidemiology,2022,33(1):118-124(期刊论文)
(5) Yang Liu; Chengdong Xu; Feiyan Liu, Gexin Xiao, Shaogi Zhou, Liming Huang: Ni Lin; jianyi Li: Dong Chen; Qi Fu; Huijun Wang; QingfengDu, Uneven development of the lead industry leads to regional differences in blood lead levels of children, Environmental Pollution, 2022,293:118504(期刊论文)
(6)Luo P, Zhang Q, $hen $, An Y, Yuan L, Wong YK, Huang s, Huang s, Huang y, Cheng G, Tian J, chen Y, Zhang X, Li w, He S, Wang d, Du Q. Mechanistic engineering of celastrol liposomes induces ferroptosis and apoptosis by directly targeting VDAc2 in hepatocellular carcinoma. Asian J Pharm Sci. 2023 Nov,18(6)100874.
(7)Wu J, Sun X, Wu C, Hong X, Xie L, Shi Z, Zhao L, Du Q, Xiao W, Sun J, Wang J. Single-cell transcriptome analysis reveals liver injury induced by glyphosate in mice. Cell Mol Biol Lett. 2023 Feb 4;28(1):11.
(8)Sun J, Yang X, Sun H, Huang S, An H, Xu W, Chen W, Zhao W, He C, Zhong X, Li T, Liu Y, Wen B, Du Q, He S. Baicalin inhibits hepatocellular carcinoma cell growth and metastasis by suppressing ROCK1 signaling. Phytother Res. 2023 Sep;37(9):4117-4132.
(9)Liang M, He M, Zhong Z, Wan B, Du Q, Mai S. Catalytic and Base-free Suzuki-type α-Arylation of Cyclic 1,3-Dicarbonyls via a Cyclic Iodonium Ylide Strategy. Angew Chem Int Ed Engl. 2024 Apr 22;63(17):e202400741.
(10)Luo P, An Y, He J, Xing X, Zhang Q, Liu X, Chen Y, Yuan H, Chen J, Wong YK, Huang J, Gong Z, Du Q, Xiao W, Wang J. Icaritin with autophagy/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1/Parkin-mediated mitophagy in hepatocellular carcinoma. Cancer Lett. 2024 Apr 10;587:216621.
(11)Jiahang Tian, Kun Chen, Qian Zhang, Chong Qiu, Haibo Tong, Jingnan Huang, Mingjing Hao, Junhui Chen, Wentong Zhao, Yin-Kwan Wong, Lei Gao, Piao Luo, Jigang Wang, Qingfeng Du. Mechanism of Self-Assembled Celastrol-Erianin Nanomedicine for treatment of breast cancer.Chemical Engineering Journal. 2024 Nov 499; 155709
(12)Zhang H, You Y, Xu J, Jiang H, Jiang J, Su Z, Chao Z, Du Q, He F. New sesquiterpenes and viridin derivatives from Penicillium sp. Ameliorates NAFLD by regulating the PINK1/Parkin mitophagy pathway. Bioorg Chem. 2024 Oct;151:107656.
(13)Huang S, Liang H, Chen Y, Liu C, Luo P, Wang H, Du Q. Hypoxanthine ameliorates diet-induced insulin resistance by improving hepatic lipid metabolism and gluconeogenesis via AMPK/mTOR/PPARα pathway. Life Sci. 2024 Nov 15;357:123096.
(14)Zhang J, Zhao X, Tang J, Liu C, Zhang Y, Cai C, Du Q. Sleep restriction exacerbates cardiac dysfunction in diabetic mice by causing cardiomyocyte death and fibrosis through mitochondrial damage. Cell Death Discov. 2024 Oct 21;10(1):446.